E, Q., F, S., A, C., S, S., & GS, F. (2025). AXL Inhibitors in Oncology Clinical Trials: A Review. Journal of immunotherapy and precision oncology, 9(1), 1. https://doi.org/10.36401/JIPO-24-37
Chicago Style (17th ed.) CitationE, Quach, Sanginova F, Cheruku A, Stack S, and Falchook GS. "AXL Inhibitors in Oncology Clinical Trials: A Review." Journal of Immunotherapy and Precision Oncology 9, no. 1 (2025): 1. https://doi.org/10.36401/JIPO-24-37.
MLA (9th ed.) CitationE, Quach, et al. "AXL Inhibitors in Oncology Clinical Trials: A Review." Journal of Immunotherapy and Precision Oncology, vol. 9, no. 1, 2025, p. 1, https://doi.org/10.36401/JIPO-24-37.
Warning: These citations may not always be 100% accurate.